Revolutionary CBD Shield: Scientists Unveil Cellular Defense Against Sun's Assault!
- MINO Labs' CBD cream, CannaXR, is the first to show UVA DNA damage reduction in human skin.
- Breakthrough Z-pods™ delivery system unleashes CBD's full protective power.
- Study published in JAAD offers new hope against photoaging and skin cancer.
The battle against the sun's silent assault on our skin has a formidable new champion. MINO Labs has just unveiled a landmark human clinical study, published in the prestigious Journal of the American Academy of Dermatology (JAAD), demonstrating the extraordinary protective power of its patented CBD cream, CannaXR, against damaging UVA radiation1. As Skin Cancer Awareness Month dawns, this breakthrough couldn't be more critical.
For too long, CBD's vast skin benefits, including potent anti-inflammatory and antioxidant properties, were hampered by its inability to truly penetrate the skin1. But MINO Labs' innovative Z-pods™ delivery system has shattered that barrier, allowing CannaXR to dive deep and work its magic at a cellular level. This first-ever human trial revealed that CannaXR significantly reduces UVA-induced DNA damage, preventing the very mutations in nuclear and mitochondrial DNA that accelerate skin aging and can lead to skin cancer1, 2. Astonishingly, volunteers saw a 21% reduction in skin redness (erythema) and less skin thickening after UVA exposure on treated areas2.
"This landmark study represents a major advance in dermatological protection and anti-aging science," declared a past Vice President of the American Academy of Dermatology. With skin cancer remaining the most diagnosed cancer in the U.S., this isn't just skincare—it's a molecular shield, offering a new category of sun protection that complements traditional sunscreens by targeting internal cellular damage. As we head towards "Don't Fry Day," MINO Labs is arming us with science-backed hope for healthier, resilient skin. The full study details are available in the Journal of the American Academy of Dermatology.
References
Stay Updated!
Get the latest biotech and pharma news delivered to your inbox.